Eckman MH, et al. - Using Markov state transition decision model, researchers assessed whether transplanting kidneys from hepatitis C virus (HCV)-viremic donors into HCV-uninfected recipients is cost-effective. Participants included US patients undergoing maintenance hemodialysis who were on kidney transplant waiting lists. Data were extracted from Medline, bibliographies from relevant English language articles, Scientific Registry of Transplant Recipients, and the US Renal Data System. According to the findings, an increased quality-adjusted life expectancy and decreased expenses were achieved with transplanting kidneys from HCV-viremic donors into HCV-uninfected recipients vs a strategy of transplanting kidneys from HCV-unexposed donors.